Esperion Therapeutics, Inc. Share-based Payment Arrangement, Expense in USD from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Esperion Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to Q3 2025.
  • Esperion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $2.35M, a 22.3% decline year-over-year.
  • Esperion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $10.3M.
  • Esperion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12M, a 0.29% increase from 2023.
  • Esperion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12M, a 21.4% decline from 2022.
  • Esperion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.2M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Esperion Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $10.3M $2.35M -$673K -22.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $11M $2.67M -$262K -8.94% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $11.2M $2.47M -$770K -23.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $12M $2.81M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-07
Q3 2024 $3.02M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $2.93M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $3.24M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2019 $6.4M +$600K +10.3% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q3 2018 $21M $5.3M +$400K +8.16% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $20.6M $5.5M +$700K +14.6% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $19.9M $5.8M +$1.7M +41.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $18.2M $4.4M +$900K +25.7% Oct 1, 2017 Dec 31, 2017 10-K 2018-02-20
Q3 2017 $17.3M $4.9M +$1.3M +36.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $16M $4.8M +$800K +20% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $15.2M $4.1M -$400K -8.89% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $15.6M $3.5M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-20
Q3 2016 $3.6M +$300K +9.09% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $4M +$1.1M +37.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $4.5M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q3 2015 $3.3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $2.9M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04

Esperion Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12M +$35K +0.29% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 $12M -$3.26M -21.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 $15.2M Jan 1, 2022 Dec 31, 2022 10-K 2025-03-07
2017 $18.2M +$2.6M +16.7% Jan 1, 2017 Dec 31, 2017 10-K 2018-02-20
2016 $15.6M +$3M +23.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-20
2015 $12.6M +$8.9M +241% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 $3.7M +$2.5M +208% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $1.2M +$1.1M +1100% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $100K +$21.5K +27.5% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-10
2011 $78.5K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.